Detrimental Effects of Nw-nitro-L-arginine Methyl Ester (L-NAME) in Experimental Escherichia coli Sepsis in the Newborn Piglet

Journal of Korean Medical Science

Volumn 18, Issue 5, 2003, Pages 637-640

  Kim, Sung Shin ^a   Hwang, Jong Hee ^b   Choi, Chang Won ^b   Shim, Jae Won ^b   Chang, Yun Sil ^b   Park, Won Soon ^b,d   Oh, Chang Kyu ^c  

^a Soonchunhyang University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d Samsung Medical Center   (South Korea)

Author keywords

Animals, Newborn; Escherichia coli; NG Nitroarginine Methyl Ester; Nitric Oxide; Sepsis

Indexed keywords

LACTIC ACID; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; THROMBIN ANTITHROMBIN COMPLEX;

ALKALINITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PH; ARTICLE; BACTERIAL INFECTION; COLONY FORMING UNIT; CONTROLLED STUDY; ESCHERICHIA COLI; HYPOTENSION; LACTATE BLOOD LEVEL; LEUKOPENIA; NEWBORN; NEWBORN SEPSIS; NONHUMAN; OXYGEN TENSION; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; SURVIVAL RATE; SWINE; THROMBOCYTOPENIA;

EID: 0347595695     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2003.18.5.637     Document Type: Article

References (24)

1. Klein JO. Bacterial sepsis and meningitis. In: Remington JS, Klein JO, editors, Infectious diseases of the fetus and newborn infant. Philadelphia: WB Saunders, 2001; 943-98.
2. Polin RA, St Geme JW III. Neonatal sepsis. Adv Pediatr Infect Dis 1992; 7: 25-61.
3. Powell KR. Sepsis and shock. In: Behrman RE, Kliegman RM, Arvin AM, editors, Nelson textbook of pediatrics. Philadelphia: WB Saunders, 2000; 747-51.
4. Feihl F, Waeber B, Liaudet L. Is nitric oxide overproduction the target of choice for the management of septic shock? Pharmacol Ther 2001; 91: 179-213.
5. Avontuur JAM, Nolthenius RPT, Buijk SLC, Kanhai KJK, Bruining HA. Effect of L-NAME, an inhibitor of nitric oxide synthesis, on cardiopulmonary function in human septic shock. Chest 1998; 113: 1640-6.
6. Petros A, Bennett D, Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991; 338: 1557-8.
7. Broccard A, Hurni JM, Eckert P, Liaudet L, Schaller MD, Lazor R, Perret C, Feihl F. Tissue oxygenation and hemodynamic response to NO synthase inhibition in septic shock. Shock 2000; 14: 35-40.
8. Kiehl MG, Ostermann H, Meyer J, Kienast J. Nitric oxide synthase inhibition by L-NAME in leukocytopenic patients with severe septic shock. Intensive Care Med 1997; 23: 561-6.
9. G-monomethyl-L-arginine improves survival in a pig model of abdominal sepsis. Crit Care Med 1998; 26: 1490-9.
10. Korbut R, Warner TD, Gryglewski RJ, Vane JR. The effect of nitric oxide synthase inhibition on the plasma fibrinolytic system in septic shock in rats. Br J Pharmacol 1994; 112: 289-91.
11. Robertson FM, Offner PJ, Ciceri DP, Becker WK, Pruitt BA. Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock. Arch Surg 1994; 129: 149-55.
12. Meadow W, Rudinsky B, Bell A, Hipps R. Effects of inhibition of endothelium-derived relaxation factor on hemodynamics and oxygen utilization during group B streptococcal sepsis in piglets. Crit Care Med 1995; 23: 705-14.
13. Gibson RL, Berger JI, Redding GJ, Standaert TA, Maycock DE, Truog WE. Effect of nitric oxide synthase inhibition during group B streptococcal sepsis in neonatal piglets. Pediatr Res 1994; 36: 776-83.
14. Barrington KJ, Etches PC, Schulz R, Talbot JA, Graham AJ, Pearson J, Cheung PY. The hemodynamic effects of inhaled nitric oxide and endogenous nitric oxide synthesis blockade in newborn piglets during infusion of heat-killed group B streptococci. Crit Care Med 2000; 28: 800-8.
15. Cobb JP, Natanson C, Quezado ZMN, Hoffman WD, Koev CA, Banks S, Correa R, Levi R, Elin RJ, Hosseini JM, Danner RL. Differential hemodynamic effects of L-NMMA in endotoxemic and normal dogs. Am J Physiol 1995; 268: H1634-42.
16. Minnard EA, Shou J, Naama H, Cech A, Gallagher H, Daly JM. Inhibition of nitric oxide synthesis is detrimental during endotoxemia. Arch Surg 1994; 129: 142-7.
17. Avontuur JAM, Nolthenius RPT, van Bodegom JW, Bruining HA. Prolonged inhibition of nitric oxide synthesis in severe septic shock: A clinical study. Crit Care Med 1998; 26: 660-7.
18. Fukatsu K, Saito H, Fukushima R, Inoue T, Lin MT, Inaba T, Muto T. Detrimental effects of a nitric oxide synthase inhibitor (N-w-nitro-L-arginine- methyl-ester) in a murine sepsis model. Arch Surg 1995; 130: 410-4.
19. w-nitro-L-arginine methyl ester on the endotoxin-induced disseminated intravascular coagulation in porcine septic shock. Crit Care Med 1997; 25: 452-9.
20. Raju TNK. Some animal models for the study of perinatal asphyxia. Biol Neonate 1992; 62: 202-14.
21. w-nitro-L-arginine methyl ester (L-NAME) attenuates the acute inflammatory responses and brain injury during the early phase of experimental Escherichia coli meningitis in the newborn piglet. Neurol Res 2001; 23: 862-8.
22. Yao SK, Ober JC, Krishnaswami A, Ferguson JJ, Anderson V, Golino P, Buja LM, Willerson JT. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries. Circulation 1991; 86: 1302-9.
23. Kubes P, Suzuki M, Granger D. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88: 4651-5.
24. Kurose I, Kubes P, Wolf R, Anderson DC, Paulson J, Miyasaka M, Granger DN. Inhibition of nitric oxide production, mechanisms of vascular albumin leakage. Circ Res 1993; 73: 164-71.